Products Categories
CAS No.: | 58581-89-8 |
---|---|
Name: | Azelastine |
Article Data: | 7 |
Molecular Structure: | |
Formula: | C22H24ClN3O |
Molecular Weight: | 381.905 |
Synonyms: | 4-[(4-chlorophenyl)methyl]-2-(1-methylazepan-4-yl)-phthalazin-1-one; |
EINECS: | 253-720-4 |
Density: | 1.25 g/cm3 |
Boiling Point: | 533.9 °C at 760 mmHg |
Flash Point: | 276.7 °C |
Appearance: | white crystal powder |
Hazard Symbols: | N,T |
Risk Codes: | R50/53; R23/25 |
PSA: | 38.13000 |
LogP: | 4.23540 |
4-[(4-chlorophenyl)methyl]-1(2H)-phthalazinone
B
azelastine
Conditions | Yield |
---|---|
With sodium hydroxide at 70℃; for 1h; Yield given; |
2‐(4-chlorophenylacetyl)benzoic acid
azelastine
Conditions | Yield |
---|---|
With hydrogenchloride; potassium hydroxide 1.) reflux, 3 h, 2.) methanol, reflux, 2 h; Yield given. Multistep reaction; |
4-chlorophenylacetic Acid
azelastine
Conditions | Yield |
---|---|
Multi-step reaction with 3 steps 1: CH3COONa / 3 h / 245 - 250 °C 2: aq. NaOH / 2 h / Heating 3: 1.) 23percent aq. HCl, 2.) KOH / 1.) reflux, 3 h, 2.) methanol, reflux, 2 h View Scheme | |
Multi-step reaction with 4 steps 1: CH3COONa / 3 h / 245 - 250 °C 2: aq. NaOH / 2 h / Heating 3: 90 percent / hydrazine sulfate, aq. NaOH / 2 h / Heating 4: aq. NaOH / 1 h / 70 °C View Scheme |
1-methyl-1,2,3,5,6,7-hexahydroazepin-4-one
azelastine
Conditions | Yield |
---|---|
Multi-step reaction with 2 steps 1: 2.) NaBH4 / 1.) CH3OH, room temp. 2: 1.) 23percent aq. HCl, 2.) KOH / 1.) reflux, 3 h, 2.) methanol, reflux, 2 h View Scheme | |
Multi-step reaction with 3 steps 1.1: potassium hydroxide / water / 1 h / 25 - 35 °C 1.2: 2 h / 0 - 10 °C 2.1: tetrahydrofuran / 1 h / 0 - 10 °C / Reflux 3.1: hydrogenchloride / 2 h / 20 °C / Reflux 3.2: 2 h / Reflux View Scheme | |
Multi-step reaction with 3 steps 1.1: potassium hydroxide / water / 1 h / 25 - 35 °C 1.2: 2 h / 0 - 10 °C 2.1: tetrahydrofuran / 1 h / 0 - 10 °C / Reflux 3.1: hydrogenchloride / 2 h / 20 °C / Reflux 3.2: 2 h / Reflux View Scheme | |
Multi-step reaction with 3 steps 1.1: potassium hydroxide / water / 1 h / 25 - 35 °C 1.2: 2 h / 0 - 10 °C 2.1: acetonitrile / 1 h / 0 - 10 °C / Reflux 3.1: hydrogenchloride / 2 h / 20 °C / Reflux 3.2: 2 h / Reflux View Scheme |
phthalic anhydride
azelastine
Conditions | Yield |
---|---|
Multi-step reaction with 3 steps 1: CH3COONa / 3 h / 245 - 250 °C 2: aq. NaOH / 2 h / Heating 3: 1.) 23percent aq. HCl, 2.) KOH / 1.) reflux, 3 h, 2.) methanol, reflux, 2 h View Scheme | |
Multi-step reaction with 4 steps 1: CH3COONa / 3 h / 245 - 250 °C 2: aq. NaOH / 2 h / Heating 3: 90 percent / hydrazine sulfate, aq. NaOH / 2 h / Heating 4: aq. NaOH / 1 h / 70 °C View Scheme |
(Z)-3-(4-chlorophenyl)methylidenephthalide
azelastine
Conditions | Yield |
---|---|
Multi-step reaction with 2 steps 1: aq. NaOH / 2 h / Heating 2: 1.) 23percent aq. HCl, 2.) KOH / 1.) reflux, 3 h, 2.) methanol, reflux, 2 h View Scheme | |
Multi-step reaction with 3 steps 1: aq. NaOH / 2 h / Heating 2: 90 percent / hydrazine sulfate, aq. NaOH / 2 h / Heating 3: aq. NaOH / 1 h / 70 °C View Scheme |
2‐(4-chlorophenylacetyl)benzoic acid
azelastine
Conditions | Yield |
---|---|
Multi-step reaction with 2 steps 1: 90 percent / hydrazine sulfate, aq. NaOH / 2 h / Heating 2: aq. NaOH / 1 h / 70 °C View Scheme |
2‐(4-chlorophenylacetyl)benzoic acid
azelastine
Conditions | Yield |
---|---|
Stage #1: 1H-azepine, 4-hydrazinohexahydro-1-methyl, dihydrochloride; 2‐(4-chlorophenylacetyl)benzoic acid With sodium hydroxide In methanol; water for 4h; Heating / reflux; Stage #2: With hydrogenchloride In methanol; 2,8-dimethylnonan-5-one; water |
azelastine hydrochloride
azelastine
Conditions | Yield |
---|---|
With sodium hydroxide In water pH=10; Inert atmosphere; |
Conditions | Yield |
---|---|
Stage #1: C14H23N3O(2+)*C4H2O4(2-) With hydrogenchloride at 20℃; for 2h; Reflux; Stage #2: 2‐(4-chlorophenylacetyl)benzoic acid for 2h; Reflux; | 8.1 g |
Chemical Name: Azelastine
IUPAC Name: 4-[(4-Chlorophenyl)methyl]-2-(1-methylazepan-4-yl)phthalazin-1-one
CAS No.: 58581-89-8
Molecular Formula: C22H24ClN3O
Molecular Weight: 381.9 g/mol
Polar Surface Area: 35.91 Å2
Index of Refraction: 1.641
Molar Refractivity: 109.97 cm3
Molar Volume: 304.5 cm3
Surface Tension: 47.4 dyne/cm
Density: 1.25 g/cm3
Flash Point: 276.7 °C
Enthalpy of Vaporization: 81 kJ/mol
Boiling Point: 533.9 °C at 760 mmHg
Vapour Pressure: 1.77E-11 mmHg at 25°C
Following is the structure of Azelastine (CAS NO.58581-89-8):
The chemical synonymous of Azelastine (CAS NO.58581-89-8) are 1(2h)-phthalazinone,4-((4-chlorophenyl)methyl)-2-(hexahydro-1-methyl-1h-azepin ; 4-(p-chlorobenzyl)-2-(hexahydro-1-methyl-1h-azepin-4-yl)-1-(2h)-phthalazinon ; AZELASTINE ; 1(2H)-Phthalazinone, 4-[(4-chlorophenyl)methyl]-2-(hexahydro-1-methyl-1H-azepin-4-yl)- ; 4-[(4-chlorophenyl)methyl]-2-(1-methylazepan-4-yl)-phthalazin-1-one ; CAS 790307-93-0 ; 4-[(4-chlorophenyl)methyl]-2-(hexahydro-1-methyl-1H-azepin-4-y1)-1(2H)-phthalazinone .
Azelastine (CAS NO.58581-89-8) is used for bronchial asthma, nasalallergy treatment.and used as a nasal spray (Astelin or Astepro)for hay fever and as eye drops (Optivar) for allergicconjunctivitis.
dog | LD50 | intravenous | 13700ug/kg (13.7mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY) GASTROINTESTINAL: NAUSEA OR VOMITING | Arzneimittel-Forschung. Drug Research. Vol. 31, Pg. 1184, 1981. |
dog | LD50 | oral | 51300ug/kg (51.3mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY) GASTROINTESTINAL: NAUSEA OR VOMITING | Arzneimittel-Forschung. Drug Research. Vol. 31, Pg. 1184, 1981. |
mouse | LD50 | intramuscular | 59700ug/kg (59.7mg/kg) | Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 17, Pg. 1106, 1986. | |
mouse | LD50 | intraperitoneal | 42800ug/kg (42.8mg/kg) | PERIPHERAL NERVE AND SENSATION: FLACCID PARALYSIS WITHOUT ANESTHESIA (USUALLY NEUROMUSCULAR BLOCKAGE) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES | Arzneimittel-Forschung. Drug Research. Vol. 31, Pg. 1184, 1981. |
mouse | LD50 | intravenous | 25400ug/kg (25.4mg/kg) | Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 17, Pg. 1106, 1986. | |
mouse | LD50 | oral | 124mg/kg (124mg/kg) | PERIPHERAL NERVE AND SENSATION: FLACCID PARALYSIS WITHOUT ANESTHESIA (USUALLY NEUROMUSCULAR BLOCKAGE) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES | Arzneimittel-Forschung. Drug Research. Vol. 31, Pg. 1184, 1981. |
mouse | LD50 | subcutaneous | 54200ug/kg (54.2mg/kg) | PERIPHERAL NERVE AND SENSATION: FLACCID PARALYSIS WITHOUT ANESTHESIA (USUALLY NEUROMUSCULAR BLOCKAGE) LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Arzneimittel-Forschung. Drug Research. Vol. 31, Pg. 1184, 1981. |
rat | LD50 | intramuscular | 115mg/kg (115mg/kg) | Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 17, Pg. 1106, 1986. | |
rat | LD50 | intraperitoneal | 43200ug/kg (43.2mg/kg) | PERIPHERAL NERVE AND SENSATION: FLACCID PARALYSIS WITHOUT ANESTHESIA (USUALLY NEUROMUSCULAR BLOCKAGE) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES | Arzneimittel-Forschung. Drug Research. Vol. 31, Pg. 1184, 1981. |
rat | LD50 | intravenous | 26900ug/kg (26.9mg/kg) | PERIPHERAL NERVE AND SENSATION: FLACCID PARALYSIS WITHOUT ANESTHESIA (USUALLY NEUROMUSCULAR BLOCKAGE) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES | Arzneimittel-Forschung. Drug Research. Vol. 31, Pg. 1184, 1981. |
rat | LD50 | oral | 310mg/kg (310mg/kg) | PERIPHERAL NERVE AND SENSATION: FLACCID PARALYSIS WITHOUT ANESTHESIA (USUALLY NEUROMUSCULAR BLOCKAGE) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES | Arzneimittel-Forschung. Drug Research. Vol. 31, Pg. 1184, 1981. |
rat | LD50 | subcutaneous | 59600ug/kg (59.6mg/kg) | PERIPHERAL NERVE AND SENSATION: FLACCID PARALYSIS WITHOUT ANESTHESIA (USUALLY NEUROMUSCULAR BLOCKAGE) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES | Arzneimittel-Forschung. Drug Research. Vol. 31, Pg. 1184, 1981. |
Poison by ingestion, subcutaneous, intravenous, and intraperitoneal routes. Experimental reproductive effects. When heated to decomposition it emits toxic fumes of NOx and Cl−.
Side effects of Azelastine (CAS NO.58581-89-8) spray vary somewhat depending on the condition being treated. The most common side effects include bitter taste, headache, rhinitis, nose bleed, and somnolence. Adults being treated for vasomotor rhinitis may also experience dysesthesia and sinusitis.